GEROPHARM is a prominent brand in the Russian pharmaceutical market, established in 2001. With more than 1500 highly skilled employees and a focus on technological innovations, GEROPHARM has secured a top 3 position in the gene-engineering human insulins market. The company is dedicated to the development and production of biotechnological products, ensuring the medicinal safety of Russia.

GEROPHARM offers a diverse portfolio of medicinal products that effectively treat socially important diseases. They have invested significantly in technological development, creating modern pharmaceutical infrastructure. Notably, GEROPHARM is a leader in diabetology and actively develops production of active pharmaceutical substances.

Driven by the ambition to create a healthy future, GEROPHARM values passion and responsibility in everything they do. They constantly strive to surpass themselves and take pride in fulfilling their commitments. Throughout their history, GEROPHARM has achieved several milestones, including the launch of original medicinal products, the development of insulin production technology, and the establishment of their own R&D Centre and manufacturing facilities.

Today, GEROPHARM is recognized as one of the leading insulin manufacturers in Russia. The brand is also dedicated to social responsibility, working closely with public organizations, doctors, patients, and reporters to address urgent healthcare issues. GEROPHARM prioritizes patient care, charity initiatives, and corporate volunteering.

For more information about their products and services, you can visit their website or contact them directly. GEROPHARM is committed to maintaining high standards of quality and making a positive impact on the healthcare industry